Proximal Ventures

Investing in founders building the future of life sciences

[Sahir Raoof @sahir_raoof]

There is no doubt that AI has the opportunity to disrupt traditionally services-heavy industries. For those who have spent any time in the life sciences, you know the web of outsourced service providers across R&D, clinical development, manufacturing, supply chain, and commercial enablement runs deep.

In Part I of a three part series, I explore how we landed on the status quo. Part II will cover China's rise in biopharma R&D and Part III breaks down what this means for founders looking to rewrite the life science playbooks.

🔗Link in comments